PEPG News and Press, PepGen Inc.

2024-07-06 15:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the expansion of its executive team with the appointments of...

2024-06-28 16:11:27 ET More on PepGen The Prognosis For PepGen Seeking Alpha’s Quant Rating on PepGen Historical earnings data for PepGen Financial information for PepGen Read the full article on Seeking Alpha For further details see: ...

2024-06-25 14:07:48 ET More on iShares Russell 2000 ETF: IWM: Small Caps Look Unattractive With Deteriorating Earnings Outlook IWM: Favor Small Caps Over The Technology Sector IWM: Not The Economy For Underdogs (Rating Downgrade) Gap between growth and small-...

2024-06-11 07:14:02 ET More on PepGen The Prognosis For PepGen Seeking Alpha’s Quant Rating on PepGen Historical earnings data for PepGen Financial information for PepGen Read the full article on Seeking Alpha For further details see: ...

Michelle Mellion, M.D., promoted to Chief Medical Officer Hayley Parker, Ph.D., promoted to Senior Vice President, Global Regulatory Affairs PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of t...

2024-05-20 13:58:20 ET Summary PepGen's stock has experienced extreme volatility, with an 80% drop, a 370% rebound, and subsequent decline in 14 months. The rebound was driven by news that Sarepta's DMD exon 51 candidate had lower skipping output than PepGen's PGN-EDO51. PepGe...

2024-05-20 09:58:45 ET More on PTC Therapeutics PTC Therapeutics: Multiple Regulatory Submissions Along With Data Cuts PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript PTC Therapeuti...

2024-05-15 10:09:12 ET More on PepGen PepGen, Inc. (PEPG) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on PepGen Historical earnings data for PepGen Financial information for PepGen Read the full article on Seeking Alpha ...

– CONNECT1-EDO51 trial preliminary data from 5mg/kg dose cohort expected mid-2024 – – FREEDOM1-DM1 trial preliminary data from at least 5mg/kg dose cohort expected second half 2024 – – N et proceeds of $86.3 million from common ...